v3.19.3
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Operating Activities:    
Net income $ 734,404 $ 1,019,853
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, amortization and impairment expense 181,028 161,726
Gain on sale and retirement of assets (29,227) (347,541)
Earnings of non-controlled entities (122,229) (130,843)
Distributions from operations of non-controlled entities 138,140 147,950
Equity-based incentive compensation expense 22,577 24,612
Settlement cost, amortization of prior service credit and actuarial loss 6,748 8,487
Debt prepayment costs 8,270 0
Changes in operating assets and liabilities:    
Trade accounts receivable and other accounts receivable (24,954) (8,303)
Inventory (20,217) 2,979
Accounts payable 29,014 27,498
Accrued payroll and benefits (13,599) (2,976)
Accrued interest payable (15,060) (21,348)
Accrued taxes other than income 10,282 964
Accrued product liabilities 33,402 (15,964)
Deferred revenue (13,233) 5,353
Other current and noncurrent assets and liabilities (2,749) (8,666)
Net cash provided by operating activities 922,597 863,781
Investing Activities:    
Additions to property, plant and equipment, net (718,605) (374,320)
Proceeds from sale and disposition of assets 65,574 579,448
Investments in non-controlled entities (158,145) (147,048)
Distributions from returns of investments in non-controlled entities 7,500 1,786
Deposits received from undivided joint interest third party 68,928 41,571
Net cash provided (used) by investing activities (734,748) 101,437
Financing Activities:    
Distributions paid (688,635) (642,370)
Borrowings under long-term notes 996,405 0
Payments on notes (550,000) (250,000)
Debt placement costs (12,012) (326)
Net receipt (payment) on financial derivatives (33,342) 20,925
Payments associated with settlement of equity-based incentive compensation (9,764) (9,285)
Debt prepayment costs (8,270) 0
Net cash used by financing activities (305,618) (881,056)
Change in cash, cash equivalents and restricted cash (117,769) 84,162
Cash, cash equivalents and restricted cash at beginning of period 309,261 176,068
Cash, cash equivalents and restricted cash at end of period 191,492 260,230
Supplemental non-cash investing activities:    
Additions to property, plant and equipment (775,109) (375,599)
Changes in accounts payable and other current liabilities related to capital expenditures 56,504 1,279
Additions to property, plant and equipment, net $ (718,605) $ (374,320)